GB8908250D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB8908250D0
GB8908250D0 GB898908250A GB8908250A GB8908250D0 GB 8908250 D0 GB8908250 D0 GB 8908250D0 GB 898908250 A GB898908250 A GB 898908250A GB 8908250 A GB8908250 A GB 8908250A GB 8908250 D0 GB8908250 D0 GB 8908250D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898908250A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB898908250A priority Critical patent/GB8908250D0/en
Publication of GB8908250D0 publication Critical patent/GB8908250D0/en
Priority to EP90905606A priority patent/EP0467916A1/en
Priority to PCT/GB1990/000513 priority patent/WO1990011754A1/en
Priority to JP2505638A priority patent/JPH04504419A/en
Priority to GR900100280A priority patent/GR900100280A/en
Priority to PT93739A priority patent/PT93739A/en
Priority to CA002014401A priority patent/CA2014401A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
GB898908250A 1989-04-12 1989-04-12 Formulations Pending GB8908250D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB898908250A GB8908250D0 (en) 1989-04-12 1989-04-12 Formulations
EP90905606A EP0467916A1 (en) 1989-04-12 1990-04-05 Aerosolized azole antifungals
PCT/GB1990/000513 WO1990011754A1 (en) 1989-04-12 1990-04-05 Aerosolized azole antifungals
JP2505638A JPH04504419A (en) 1989-04-12 1990-04-05 Aerosolized azole antimicrobial agent
GR900100280A GR900100280A (en) 1989-04-12 1990-04-10 Aerosolized azole antifungals
PT93739A PT93739A (en) 1989-04-12 1990-04-11 PROCESS FOR THE PREPARATION OF ANTI-FUNGIC COMPOSITIONS IN THE FORM OF AEROSOLS CONTAINING AZOIS
CA002014401A CA2014401A1 (en) 1989-04-12 1990-04-11 Aerosolised azole anti fungals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908250A GB8908250D0 (en) 1989-04-12 1989-04-12 Formulations

Publications (1)

Publication Number Publication Date
GB8908250D0 true GB8908250D0 (en) 1989-05-24

Family

ID=10654880

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898908250A Pending GB8908250D0 (en) 1989-04-12 1989-04-12 Formulations

Country Status (7)

Country Link
EP (1) EP0467916A1 (en)
JP (1) JPH04504419A (en)
CA (1) CA2014401A1 (en)
GB (1) GB8908250D0 (en)
GR (1) GR900100280A (en)
PT (1) PT93739A (en)
WO (1) WO1990011754A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8055691A (en) * 1990-06-29 1992-01-23 Fisons Plc Pressurised aerosol compositions
EP0587790B2 (en) 1991-06-10 2000-03-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IT1253711B (en) * 1991-12-17 1995-08-23 Alfa Wassermann Spa VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DK0631578T3 (en) * 1992-03-18 2001-08-27 Janssen Pharmaceutica Nv Itraconazole and saperconazole stereoisomers
EP0680324A4 (en) * 1993-01-27 1996-04-10 Sepracor Inc Method and composition employing (2r,4s) itraconazole.
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Pharmaceutical preparations from coated, poorly water-soluble pharmaceutical substances for inhalation pharmaceutical forms and processes for their preparation
JP2875140B2 (en) * 1993-08-16 1999-03-24 明治製菓株式会社 Anti-MRSA composition
NL1006103C2 (en) * 1997-05-21 1998-11-25 Nutricia Nv Powder-based skin spray.
EP1037752B1 (en) 1997-12-09 2003-10-08 The Goodyear Tire & Rubber Company Pneumatic tyre having a transponder and an annular antenna and method of manufacturing such a tyre
EP1039909B1 (en) 1997-12-31 2002-10-09 Choongwae Pharma Corporation Method of production and composition of an oral preparation of itraconazole
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
AU2002245181B2 (en) 2000-12-21 2006-06-29 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1789018A1 (en) 2004-08-27 2007-05-30 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2008124131A1 (en) * 2007-04-05 2008-10-16 The John Hopkins University Antifungal agents as neuroprotectants
MX2010011295A (en) * 2008-04-15 2010-11-12 Schering Corp Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas.
EP2601973A1 (en) 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241602A (en) * 1984-02-23 1988-09-06 Ortho Pharmaceutical Corporation Antifungal aerosol solution
JPH01153634A (en) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd Absorbing agent

Also Published As

Publication number Publication date
WO1990011754A1 (en) 1990-10-18
JPH04504419A (en) 1992-08-06
EP0467916A1 (en) 1992-01-29
PT93739A (en) 1990-11-20
GR900100280A (en) 1991-09-27
CA2014401A1 (en) 1990-10-12

Similar Documents

Publication Publication Date Title
GB8908250D0 (en) Formulations
AU108277S (en) Hedge-shears
EP0413610A3 (en) Pesticidal formulations
EP0433909A3 (en) Formulation
AP9000174A0 (en) Antiparasitical formulations
GB8914791D0 (en) Formulation
BG49771A1 (en) Electric- bow evaparator
GB8924207D0 (en) Formulations
GB8922917D0 (en) Formulations
IE894052L (en) Formulations
GB8905015D0 (en) Formulations
GB8908249D0 (en) Formulations
GB8914790D0 (en) Formulations
GB8922288D0 (en) Formulations
GB8924635D0 (en) Formulations
GB8926129D0 (en) Formulations
GB8815092D0 (en) Formulations
GB8829644D0 (en) Formulations
GB8826942D0 (en) Formulations
GB8826941D0 (en) Formulations
GB8823107D0 (en) Formulations
GB8803653D0 (en) Formulations
GB8815091D0 (en) Formulations
GB8803654D0 (en) Formulations
GB8913170D0 (en) Formulation